Global Hepatitis B Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 96 pages | ID: G1B60210D1CEEN
QYResearch

Abstracts

This report focuses on the global Hepatitis B Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hepatitis B Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Accord Healthcare Inc.
• Apotex Corp.
• Arbutus Biopharma
• Bristol-Myers Squibb Company
• Gilead Sciences
• GlaxoSmithKline
• Lupin Pharmaceuticals
• Merck & Co., Inc.
• Par Pharmaceutical
• Teva Pharmaceuticals
• Zydus Pharmaceuticals

Market segment by Type, the product can be split into

• Acute
• Chronic

Market segment by Application, split into

• Immune Modulator Drugs
• Antiviral Drugs

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Hepatitis B Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Hepatitis B Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Hepatitis B Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hepatitis B Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Hepatitis B Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Acute
  1.4.3 Chronic
1.5 Market by Application
  1.5.1 Global Hepatitis B Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Immune Modulator Drugs
  1.5.3 Antiviral Drugs
1.6 Coronavirus Disease 2019 (Covid-19): Hepatitis B Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Hepatitis B Treatment Industry
    1.6.1.1 Hepatitis B Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Hepatitis B Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Hepatitis B Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Hepatitis B Treatment Market Perspective (2015-2026)
2.2 Hepatitis B Treatment Growth Trends by Regions
  2.2.1 Hepatitis B Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Hepatitis B Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Hepatitis B Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Hepatitis B Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Hepatitis B Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Hepatitis B Treatment Players by Market Size
  3.1.1 Global Top Hepatitis B Treatment Players by Revenue (2015-2020)
  3.1.2 Global Hepatitis B Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Hepatitis B Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hepatitis B Treatment Market Concentration Ratio
  3.2.1 Global Hepatitis B Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Hepatitis B Treatment Revenue in 2019
3.3 Hepatitis B Treatment Key Players Head office and Area Served
3.4 Key Players Hepatitis B Treatment Product Solution and Service
3.5 Date of Enter into Hepatitis B Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Hepatitis B Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hepatitis B Treatment Forecasted Market Size by Type (2021-2026)

5 HEPATITIS B TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Hepatitis B Treatment Market Size by Application (2015-2020)
5.2 Global Hepatitis B Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Hepatitis B Treatment Market Size (2015-2020)
6.2 Hepatitis B Treatment Key Players in North America (2019-2020)
6.3 North America Hepatitis B Treatment Market Size by Type (2015-2020)
6.4 North America Hepatitis B Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Hepatitis B Treatment Market Size (2015-2020)
7.2 Hepatitis B Treatment Key Players in Europe (2019-2020)
7.3 Europe Hepatitis B Treatment Market Size by Type (2015-2020)
7.4 Europe Hepatitis B Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Hepatitis B Treatment Market Size (2015-2020)
8.2 Hepatitis B Treatment Key Players in China (2019-2020)
8.3 China Hepatitis B Treatment Market Size by Type (2015-2020)
8.4 China Hepatitis B Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Hepatitis B Treatment Market Size (2015-2020)
9.2 Hepatitis B Treatment Key Players in Japan (2019-2020)
9.3 Japan Hepatitis B Treatment Market Size by Type (2015-2020)
9.4 Japan Hepatitis B Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Hepatitis B Treatment Market Size (2015-2020)
10.2 Hepatitis B Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hepatitis B Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hepatitis B Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Hepatitis B Treatment Market Size (2015-2020)
11.2 Hepatitis B Treatment Key Players in India (2019-2020)
11.3 India Hepatitis B Treatment Market Size by Type (2015-2020)
11.4 India Hepatitis B Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Hepatitis B Treatment Market Size (2015-2020)
12.2 Hepatitis B Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hepatitis B Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hepatitis B Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Accord Healthcare Inc.
  13.1.1 Accord Healthcare Inc. Company Details
  13.1.2 Accord Healthcare Inc. Business Overview and Its Total Revenue
  13.1.3 Accord Healthcare Inc. Hepatitis B Treatment Introduction
  13.1.4 Accord Healthcare Inc. Revenue in Hepatitis B Treatment Business (2015-2020))
  13.1.5 Accord Healthcare Inc. Recent Development
13.2 Apotex Corp.
  13.2.1 Apotex Corp. Company Details
  13.2.2 Apotex Corp. Business Overview and Its Total Revenue
  13.2.3 Apotex Corp. Hepatitis B Treatment Introduction
  13.2.4 Apotex Corp. Revenue in Hepatitis B Treatment Business (2015-2020)
  13.2.5 Apotex Corp. Recent Development
13.3 Arbutus Biopharma
  13.3.1 Arbutus Biopharma Company Details
  13.3.2 Arbutus Biopharma Business Overview and Its Total Revenue
  13.3.3 Arbutus Biopharma Hepatitis B Treatment Introduction
  13.3.4 Arbutus Biopharma Revenue in Hepatitis B Treatment Business (2015-2020)
  13.3.5 Arbutus Biopharma Recent Development
13.4 Bristol-Myers Squibb Company
  13.4.1 Bristol-Myers Squibb Company Company Details
  13.4.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
  13.4.3 Bristol-Myers Squibb Company Hepatitis B Treatment Introduction
  13.4.4 Bristol-Myers Squibb Company Revenue in Hepatitis B Treatment Business (2015-2020)
  13.4.5 Bristol-Myers Squibb Company Recent Development
13.5 Gilead Sciences
  13.5.1 Gilead Sciences Company Details
  13.5.2 Gilead Sciences Business Overview and Its Total Revenue
  13.5.3 Gilead Sciences Hepatitis B Treatment Introduction
  13.5.4 Gilead Sciences Revenue in Hepatitis B Treatment Business (2015-2020)
  13.5.5 Gilead Sciences Recent Development
13.6 GlaxoSmithKline
  13.6.1 GlaxoSmithKline Company Details
  13.6.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.6.3 GlaxoSmithKline Hepatitis B Treatment Introduction
  13.6.4 GlaxoSmithKline Revenue in Hepatitis B Treatment Business (2015-2020)
  13.6.5 GlaxoSmithKline Recent Development
13.7 Lupin Pharmaceuticals
  13.7.1 Lupin Pharmaceuticals Company Details
  13.7.2 Lupin Pharmaceuticals Business Overview and Its Total Revenue
  13.7.3 Lupin Pharmaceuticals Hepatitis B Treatment Introduction
  13.7.4 Lupin Pharmaceuticals Revenue in Hepatitis B Treatment Business (2015-2020)
  13.7.5 Lupin Pharmaceuticals Recent Development
13.8 Merck & Co., Inc.
  13.8.1 Merck & Co., Inc. Company Details
  13.8.2 Merck & Co., Inc. Business Overview and Its Total Revenue
  13.8.3 Merck & Co., Inc. Hepatitis B Treatment Introduction
  13.8.4 Merck & Co., Inc. Revenue in Hepatitis B Treatment Business (2015-2020)
  13.8.5 Merck & Co., Inc. Recent Development
13.9 Par Pharmaceutical
  13.9.1 Par Pharmaceutical Company Details
  13.9.2 Par Pharmaceutical Business Overview and Its Total Revenue
  13.9.3 Par Pharmaceutical Hepatitis B Treatment Introduction
  13.9.4 Par Pharmaceutical Revenue in Hepatitis B Treatment Business (2015-2020)
  13.9.5 Par Pharmaceutical Recent Development
13.10 Teva Pharmaceuticals
  13.10.1 Teva Pharmaceuticals Company Details
  13.10.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
  13.10.3 Teva Pharmaceuticals Hepatitis B Treatment Introduction
  13.10.4 Teva Pharmaceuticals Revenue in Hepatitis B Treatment Business (2015-2020)
  13.10.5 Teva Pharmaceuticals Recent Development
13.11 Zydus Pharmaceuticals
  10.11.1 Zydus Pharmaceuticals Company Details
  10.11.2 Zydus Pharmaceuticals Business Overview and Its Total Revenue
  10.11.3 Zydus Pharmaceuticals Hepatitis B Treatment Introduction
  10.11.4 Zydus Pharmaceuticals Revenue in Hepatitis B Treatment Business (2015-2020)
  10.11.5 Zydus Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Hepatitis B Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hepatitis B Treatment Revenue
Table 3. Ranking of Global Top Hepatitis B Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hepatitis B Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acute
Table 6. Key Players of Chronic
Table 7. COVID-19 Impact Global Market: (Four Hepatitis B Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Hepatitis B Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Hepatitis B Treatment Players to Combat Covid-19 Impact
Table 12. Global Hepatitis B Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Hepatitis B Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Hepatitis B Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Hepatitis B Treatment Market Share by Regions (2015-2020)
Table 16. Global Hepatitis B Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Hepatitis B Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Hepatitis B Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Hepatitis B Treatment Players
Table 23. Global Hepatitis B Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Hepatitis B Treatment Market Share by Players (2015-2020)
Table 25. Global Top Hepatitis B Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Treatment as of 2019)
Table 26. Global Hepatitis B Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Hepatitis B Treatment Product Solution and Service
Table 29. Date of Enter into Hepatitis B Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Hepatitis B Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Hepatitis B Treatment Market Size Share by Type (2015-2020)
Table 33. Global Hepatitis B Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Hepatitis B Treatment Market Size Share by Application (2015-2020)
Table 35. Global Hepatitis B Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Hepatitis B Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Hepatitis B Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Hepatitis B Treatment Market Share (2019-2020)
Table 39. North America Hepatitis B Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Hepatitis B Treatment Market Share by Type (2015-2020)
Table 41. North America Hepatitis B Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Hepatitis B Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Hepatitis B Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Hepatitis B Treatment Market Share (2019-2020)
Table 45. Europe Hepatitis B Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Hepatitis B Treatment Market Share by Type (2015-2020)
Table 47. Europe Hepatitis B Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Hepatitis B Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Hepatitis B Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Hepatitis B Treatment Market Share (2019-2020)
Table 51. China Hepatitis B Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Hepatitis B Treatment Market Share by Type (2015-2020)
Table 53. China Hepatitis B Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Hepatitis B Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Hepatitis B Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Hepatitis B Treatment Market Share (2019-2020)
Table 57. Japan Hepatitis B Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Hepatitis B Treatment Market Share by Type (2015-2020)
Table 59. Japan Hepatitis B Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Hepatitis B Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Hepatitis B Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Hepatitis B Treatment Market Share (2019-2020)
Table 63. Southeast Asia Hepatitis B Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Hepatitis B Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Hepatitis B Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Hepatitis B Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Hepatitis B Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Hepatitis B Treatment Market Share (2019-2020)
Table 69. India Hepatitis B Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Hepatitis B Treatment Market Share by Type (2015-2020)
Table 71. India Hepatitis B Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Hepatitis B Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Hepatitis B Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Hepatitis B Treatment Market Share (2019-2020)
Table 75. Central & South America Hepatitis B Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Hepatitis B Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Hepatitis B Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Hepatitis B Treatment Market Share by Application (2015-2020)
Table 79. Accord Healthcare Inc. Company Details
Table 80. Accord Healthcare Inc. Business Overview
Table 81. Accord Healthcare Inc. Product
Table 82. Accord Healthcare Inc. Revenue in Hepatitis B Treatment Business (2015-2020) (Million US$)
Table 83. Accord Healthcare Inc. Recent Development
Table 84. Apotex Corp. Company Details
Table 85. Apotex Corp. Business Overview
Table 86. Apotex Corp. Product
Table 87. Apotex Corp. Revenue in Hepatitis B Treatment Business (2015-2020) (Million US$)
Table 88. Apotex Corp. Recent Development
Table 89. Arbutus Biopharma Company Details
Table 90. Arbutus Biopharma Business Overview
Table 91. Arbutus Biopharma Product
Table 92. Arbutus Biopharma Revenue in Hepatitis B Treatment Business (2015-2020) (Million US$)
Table 93. Arbutus Biopharma Recent Development
Table 94. Bristol-Myers Squibb Company Company Details
Table 95. Bristol-Myers Squibb Company Business Overview
Table 96. Bristol-Myers Squibb Company Product
Table 97. Bristol-Myers Squibb Company Revenue in Hepatitis B Treatment Business (2015-2020) (Million US$)
Table 98. Bristol-Myers Squibb Company Recent Development
Table 99. Gilead Sciences Company Details
Table 100. Gilead Sciences Business Overview
Table 101. Gilead Sciences Product
Table 102. Gilead Sciences Revenue in Hepatitis B Treatment Business (2015-2020) (Million US$)
Table 103. Gilead Sciences Recent Development
Table 104. GlaxoSmithKline Company Details
Table 105. GlaxoSmithKline Business Overview
Table 106. GlaxoSmithKline Product
Table 107. GlaxoSmithKline Revenue in Hepatitis B Treatment Business (2015-2020) (Million US$)
Table 108. GlaxoSmithKline Recent Development
Table 109. Lupin Pharmaceuticals Company Details
Table 110. Lupin Pharmaceuticals Business Overview
Table 111. Lupin Pharmaceuticals Product
Table 112. Lupin Pharmaceuticals Revenue in Hepatitis B Treatment Business (2015-2020) (Million US$)
Table 113. Lupin Pharmaceuticals Recent Development
Table 114. Merck & Co., Inc. Business Overview
Table 115. Merck & Co., Inc. Product
Table 116. Merck & Co., Inc. Company Details
Table 117. Merck & Co., Inc. Revenue in Hepatitis B Treatment Business (2015-2020) (Million US$)
Table 118. Merck & Co., Inc. Recent Development
Table 119. Par Pharmaceutical Company Details
Table 120. Par Pharmaceutical Business Overview
Table 121. Par Pharmaceutical Product
Table 122. Par Pharmaceutical Revenue in Hepatitis B Treatment Business (2015-2020) (Million US$)
Table 123. Par Pharmaceutical Recent Development
Table 124. Teva Pharmaceuticals Company Details
Table 125. Teva Pharmaceuticals Business Overview
Table 126. Teva Pharmaceuticals Product
Table 127. Teva Pharmaceuticals Revenue in Hepatitis B Treatment Business (2015-2020) (Million US$)
Table 128. Teva Pharmaceuticals Recent Development
Table 129. Zydus Pharmaceuticals Company Details
Table 130. Zydus Pharmaceuticals Business Overview
Table 131. Zydus Pharmaceuticals Product
Table 132. Zydus Pharmaceuticals Revenue in Hepatitis B Treatment Business (2015-2020) (Million US$)
Table 133. Zydus Pharmaceuticals Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Hepatitis B Treatment Market Share by Type: 2020 VS 2026
Figure 2. Acute Features
Figure 3. Chronic Features
Figure 4. Global Hepatitis B Treatment Market Share by Application: 2020 VS 2026
Figure 5. Immune Modulator Drugs Case Studies
Figure 6. Antiviral Drugs Case Studies
Figure 7. Hepatitis B Treatment Report Years Considered
Figure 8. Global Hepatitis B Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Hepatitis B Treatment Market Share by Regions: 2020 VS 2026
Figure 10. Global Hepatitis B Treatment Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Hepatitis B Treatment Market Share by Players in 2019
Figure 13. Global Top Hepatitis B Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Treatment as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Hepatitis B Treatment Revenue in 2019
Figure 15. North America Hepatitis B Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Hepatitis B Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Hepatitis B Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Hepatitis B Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Hepatitis B Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Hepatitis B Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Hepatitis B Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Accord Healthcare Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Accord Healthcare Inc. Revenue Growth Rate in Hepatitis B Treatment Business (2015-2020)
Figure 24. Apotex Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Apotex Corp. Revenue Growth Rate in Hepatitis B Treatment Business (2015-2020)
Figure 26. Arbutus Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Arbutus Biopharma Revenue Growth Rate in Hepatitis B Treatment Business (2015-2020)
Figure 28. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Bristol-Myers Squibb Company Revenue Growth Rate in Hepatitis B Treatment Business (2015-2020)
Figure 30. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Gilead Sciences Revenue Growth Rate in Hepatitis B Treatment Business (2015-2020)
Figure 32. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithKline Revenue Growth Rate in Hepatitis B Treatment Business (2015-2020)
Figure 34. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Lupin Pharmaceuticals Revenue Growth Rate in Hepatitis B Treatment Business (2015-2020)
Figure 36. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Merck & Co., Inc. Revenue Growth Rate in Hepatitis B Treatment Business (2015-2020)
Figure 38. Par Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Par Pharmaceutical Revenue Growth Rate in Hepatitis B Treatment Business (2015-2020)
Figure 40. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Teva Pharmaceuticals Revenue Growth Rate in Hepatitis B Treatment Business (2015-2020)
Figure 42. Zydus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Zydus Pharmaceuticals Revenue Growth Rate in Hepatitis B Treatment Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed